medigraphic.com

2019, Number 1

<< Back Next >>

Rev Hosp Jua Mex 2019; 86 (1)

Dengue in special populations

del Carpio OL

Language: Spanish
References: 52
Page: 33-38
PDF size: 179.50 Kb.


ABSTRACT

The present document reviews the main chronic diseases and special populations that are affected by dengue, and which are often not taken into account during the arbovirus seasons, emphasizing that some entities have their particularities that cause greater vigilance by the risk of complications and increased morbidity and mortality, such as patients with heart disease, autoimmune, renal diseases, among others. Likewise, special populations such as the pediatric population, pregnant women or older adults, who should be better supervised and monitored, are mentioned as maternal or child deaths may occur during the dengue season.


REFERENCES

  1. Del Carpio-Orantes L. Virosis emergentes en México. Rev Med del Inst Mex del Seguro Soc 2013; 51(1): 8-11.

  2. Del Carpio-Orantes L. Dengue for apparatus and systems. MEDtube Sci 2015; 3(3): 21-4.

  3. Htun NS, Odermatt P, Eze IC, Boillat-Blanco N, D’Acremont V, Probst-Hensch N. Is diabetes a risk factor for a severe clinical presentation of dengue? - Review and metaanalysis. PLoS Negl Trop Dis 2015; 9(4): e0003741.

  4. Saqib MA, Rafique I, Bashir S, et al. A retrospective analysis of dengue fever case management and frequency of co-morbidities associated with deaths. BMC Res Notes. 2014 Apr 1;7:205. doi: 10.1186/1756-0500-7-205.

  5. Pang J, Salim A, Lee VJ, Hibberd ML, Chia KS, et al. Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. PLoS Negl Trop Dis 2012; 6(5): e1641. doi: 10.1371/journal.pntd.0001641.

  6. Souza LJ, Coelho JMCO, Silva EJ, et al. Acute hepatitis due to dengue virus in a chronic hepatitis patient. The Brazilian Journal of Infectious Diseases 2008; 12(5): 456-9.

  7. Agarwal MP, Giri S, Sharma V, et al. Dengue causing fulminant hepatitis in a hepatitis B virus carrier. Bio Science Trends 2011; 5(1): 44-5. doi: 10.5582/bst.2011.v5.1.44.

  8. Puente-Saní V, García-Amelo IM, Oropesa-Roblejo P, Caballero-Artiles RA. Dengue hemorrágico en un paciente con VIH/SIDA. Primer caso informado en Santiago de Cuba. MEDISAN [Artículo en línea] 2008; 12(1).

  9. Joob B, Wiwanitkit V. Dengue in HIV infected patients: clinical profiles. Asian Pac J Trop Biomed 2014; 4(Suppl 2): S568-9. doi: 10.12980/APJTB.4.2014APJTB-2014-0161.

  10. Pesaro AE, D’Amico E, Aranha LF. Dengue: cardiac manifestations and implications in antithrombotic treatment. Arq Bras Cardiol 2007; 89(2): e12-5.

  11. Gamakaranage C, Rodrigo C, Samarawickrama S, et al. Dengue hemorrhagic fever and severe thrombocytopenia in a patient on mandatory anticoagulation: balancing two life threatening conditions: a case report. BMC Infect Dis. 2012;12:272. Published 2012 Oct 26. doi:10.1186/1471-2334-12-272

  12. Badve SV, Patil S, Rathod NM, Jumrani CK. Dengue fever and takotsubo cardiomyopathy. The Journal of the Association of Physicians of India 2015; 63(7): 67-70.

  13. Chou MT, Yu WL. Takotsubo cardiomyopathy in a patient with dengue fever. Journal of the Formosan Medical Association 2016; 115(9): 818-9.

  14. Rashid N, Sultan F, Nazeer SH, et-al. Dengue infection in cancer patients. Esculapio 2014; 10(3): 138-45.

  15. Vineet Talwar, Varun Goel, Shubhra Raina, et al. Dengue fever in cancer patients: Retrospective analysis. Current Medicine Research and Practice, ISSN: 2352-0817, Vol: 6, Issue: 4, Page: 157-159. doi: doi10.1016/j.cmrp.2016.07.010

  16. Sharma SK, Seth T, Mishra P, et-al. Clinical profile of dengue infection in patients with hematological diseases. Mediterr J Hematol Infect Dis 2011; 3: e2011039. doi 10.4084/MJHID.2011.039.

  17. De Souza LJ, Neto CG, Bastos DA, et al. Dengue and immune thrombocytopenic purpura. Dengue Bulletin 2005; 29: 136-41.

  18. Rodríguez-Angulo EM, Sosa-Muñoz J, García-Miss MR, et-al. Caso de purpura trombocitopénica autoinmune y dengue. Rev Invest Clin 1997; 49: 47-9.

  19. Palacios-Cuervo F, Calderón-Rivera A, Espinal-Reyes F, Canelo-Aybar C. Autoinmunidad en dengue: revisión bibliográfica. Reumatol Clin 2016; 12: 173-4.

  20. Yasri S, Wiwanitkit V. Dengue and lupus: the problem of co-occurrence. Asian Pac J Trop Dis 2015; 5(12): 1007-8. doi: 10.1016/S2222-1808(15)60974-4.

  21. Talib SH, Bhattu SR, Bhattu R, et al. Dengue fever triggering systemic lupus erythematosus and lupus nephritis: a case report. International Medical Case Reports Journal 2013; 6: 71-5. http://dx.doi.org/10.2147/IMCRJ.S50708

  22. Agüero S, Toloza S, Lejtman N, et al. Manifestaciones clínicas y bioquímicas asociadas a infección por virus del dengue en pacientes con enfermedades reumáticas durante un brote epidémico en la provincia de Catamarca, República Argentina. Rev Arg Reumatol 2011; 22(3): 14-28.

  23. Barraza M, Gómez R, Santacruz JG. Dengue y vasculitis leucocitoclástica. Universitas Médica 2006; 47(3): 278-83.

  24. Rajadhyaksha A, Mehra S. Dengue fever evolving into systemic lupus erythematosus and lupus nephritis: a case report. Lupus 2012; 21(9): 999-1002.

  25. Khan AH, Mallhi TH. Dengue induced nephropathies. SMGroup 2016; 1-20.

  26. Kuo MC, Chang JM, Lu PL, Chiu YW, Chen HC, Hwang SJ. Difficulty in diagnosis and treatment of dengue hemorrhagic fever in patients with chronic renal failure: report of three cases of mortality. The American Journal of Tropical Medicine and Hygiene 2007; 76: 752-6.

  27. Kuo MC, Lu PL, Chang JM, Lin MY, Tsai JJ, Chen YH, et al. Impact of renal failure on the outcome of dengue viral infection. Clin J Am Soc Nephrol 2008; 3: 1350-6.

  28. Lizarraga KJ, Nayer A. Dengue-associated kidney disease. Journal of Nephropathology 2014; 3: 57.

  29. Vasanwala FF, Puvanendran R, Ng JM, Suhail SM. Two cases of self-limiting nephropathies secondary to dengue haemorrhagic fever. Singapore Med J 2009; 50(7): e253-5.

  30. Romero-Santacruz E, Lira-Canul JJ, Pacheco-Tugores F, Palma-Chan AG. Dengue neonatal. Presentación de casos clínicos. Ginecol Obstet Mex 2015; 83: 308-15.

  31. Del Carpio-Orantes L. Zika, ¿virus neurotrópico? Rev Med Inst Mex Seg Soc 2016; 54(4): 540-3.

  32. Tan PC, Rajasingam G, Devi S, Omar SZ. Dengue infection in pregnancy: prevalence, vertical transmission, and pregnancy outcome. Obstetrics & Gynecology 2008; 111(5): 1111-7.

  33. Restrepo BN, Isaza DM, Salazar CL, Ramírez JL, Upegui GE, Ospina M, Ramírez R. Dengue en el embarazo: efectos en el feto y el recién nacido. Biomédica 2003; 23(4), 416-23. doi: https://doi.org/10.7705/biomedica.v23i4.1236

  34. Carroll ID, Toovey S, Van Gompel A. Dengue fever and pregnancy-a review and comment. Travel Medicine and Infectious Disease 2007; 5(3): 183-8.

  35. Castellanos-Morfín J, Hernández-Pérez P, Arellano-Cortés B, Newton-Sánchez OA, Espinoza-Gómez F. Reporte de un caso de dengue neonatal. Boletín médico del Hospital Infantil de México 2006; 63(3): 202-6.

  36. Córdoba C, Blanco A, Malawka J, Ojeda V. Dengue en pediatría. Revista de Posgrado de la VIa Cátedra de Medicina 2007; 168: 26-33.

  37. Rueda E, Méndez A, González G. Síndrome hemofagocítico asociado con dengue hemorrágico. Biomédica 2002; 22(2): 160-6.

  38. Salgado D, Rodríguez J, Vega R. Dengue hemorrágico emergencia pediátrica en el Huila. Pediatría (Bogotá) 1999; 34(2): 78-83.

  39. Martínez BL, Quiroz E, Bellón JM, Esquivel R, Guevara JN, Sáez-Llorens X. Dengue pediátrico en Panamá. Anales de Pediatría 2006; 64(6): 517-22.

  40. Soler RY, Garcia R, Fernandez SA. Dengue virus associated hemophagocytic syndrome in children: a case report. Boletin de la Asociacion Medica de Puerto Rico 2010; 102(1): 49-54.

  41. Balmaseda A, Standish K, Mercado JC, Matute JC, Tellez Y, Saborío S, et al. Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. The Journal of Infectious Diseases 2010; 201(1): 5-14.

  42. Potts JA, Gibbons RV, Rothman AL, Srikiatkhachorn A, Thomas SJ, Supradish PO, et al. Prediction of dengue disease severity among pediatric Thai patients using early clinical laboratory indicators. PLoS Neglected Tropical Diseases 2010; 4(8): e769.

  43. Kamath SR, Ranjit S. Clinical features, complications and atypical manifestations of children with severe forms of dengue hemorrhagic fever in South India. The Indian Journal of Pediatrics 2006; 73(10): 889-95.

  44. Rosso F, Vanegas S, Rodríguez S, et al. Prevalencia y curso clínico de la infección por dengue en adultos mayores con cuadro febril agudo en un hospital de alta complejidad en Cali, Colombia. Biomédica 2016; 36(Supl 2): 179-86. doi: http://dx.doi.org/10.7705/biomedica.v36i0.2961.

  45. Díaz A, Kouri GP, Guzmán MG, Lobaina L, Bravo JR, Ruiz A, Martínez R. Cuadro clínico de la fiebre hemorrágica del dengue/síndrome del choque del dengue en el adulto. Bol of sanit panam 1988; 104(6) 560-571

  46. García-Rivera EJ, Rigau-Pérez JG. Dengue severity in the elderly in Puerto Rico. Revista Panamericana de Salud Pública 2003; 13(6): 362-8.

  47. Gorzoni ML, Massaia IFDS, Pires SL. Dengue in an elderly patient. Revista do Instituto de Medicina Tropical de São Paulo 2010; 52(3): 163-7.

  48. Rowe EK, Leo YS, Wong JG, Thein TL, Gan VC, Lee LK, et al. Challenges in dengue fever in the elderly: atypical presentation and risk of severe dengue and hospita-acquired infection. PLoS Neglected Tropical Diseases 2014; 8(4): e2777.

  49. Lye DC, Lee VJ, Sun Y, Leo YS. The benign nature of acute dengue infection in hospitalized older adults in Singapore. International Journal of Infectious Diseases 2010; 14(5): e410-3.

  50. Lee IK, Liu JW, Yang KD. Clinical characteristics and risk factors for concurrent bacteremia in adults with dengue hemorrhagic fever. The American Journal of Tropical Medicine and Hygiene 2005; 72(2): 221-6.

  51. Lee CC, Hsu HC, Chang CM, Hong MY, Ko WC. Atypical presentations of dengue disease in the elderly visiting the ED. The American Journal of Emergency Medicine 2013; 31(5): 783-7.

  52. Yap G, Li C, Mutalib A, Lai YL, Ng LC. High rates of inapparent dengue in older adults in Singapore. The American Journal of Tropical Medicine and Hygiene 2013; 88(6): 1065-9.




2020     |     www.medigraphic.com